PMC3039197_01
(A) Slit lamp photograph of the patient's right eye on initial presentation. Note the size, salmon color, and elevated appearance of the hypervascular lesion. (B) Slit lamp photograph of the patient's left eye on initial presentation. Note the size, faint salmon color, and mildly protruding mass. (C,D) Slit lamp photograph of both eyes 2 months following subconjunctival injection of bevacizumab. The lesions appear to be almost completely resolved with no obvious remnants seen on the sclera or conjunctiva. (E) Slit lamp photograph of the patient's right eye after biopsy.
kjo-25-57-g001.jpg
PMC3039197_01_kjo-25-57-g001.jpg
F1
A faint, salmon colored, elevated (1 mm) mass (5 mm x 4 mm) on the nasal conjunctiva of the left eye, with thinner new vessels than in the right eye, was also observed (Fig. 1A and 1B). Two months after injection, both masses had almost completely disappeared and the accompanying neovascularization was reduced (Fig. 1D and 1E).
Haematoxylin and eosin staining. (A) x40 magnification of the lesion biopsied in Fig. 1A. (B) x200 magnification of the same lesion. Note the abundance of lymphocytes and the predominance of T cells (CD3+) and B cells (CD20+), a pattern typical of benign lymphoid hyperplasia.
kjo-25-57-g002.jpg
PMC3039197_01_kjo-25-57-g002.jpg
F2
Pathological examination revealed benign lymphohistiocytic infiltrates (Fig. 2).